• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3321 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: managing the risk of suicide and self-harm among youths living in rehabilitation centres for young persons with adjustment problems]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: indications justifying the use of imaging for diagnosing patients with primary or secondary headache]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in October 2019: lipid-lowering pharmacologic agents]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in July 2019: high blood pressure]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: HemlibraMC (emicizumab) - Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, updated on May 4th 2020 : guide to preventing and treating chemotherapy or radiotherapy-induced nausea and vomiting in adults]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated June 2019: palliative care - fever]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: assessing the senior care and services continuum, prospects for measurement development]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Esperoct (turoctocog alfa pegol) – Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: effects of assistance dogs and companion animals on persons with autism spectrum disorder or post-traumatic stress disorder]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: urethral discharge]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: acute exacerbations of chronic obstructive pulmonary disease (AECOPD)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Localized and disseminated stages of Lyme disease: from diagnosis to treatment, report in support of the diagnosis and treatment decision support tools]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of newborn blood spot screening for biotinidase deficiency (BIOT)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Cutaquig, preparation of human immunoglobulins, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: axicabtagene ciloleucel for the treatment of relapsed or refractory large B-cell lymphoma]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: autonomy in intellectually disabled young people aged 6 to 21 years]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: antidiabetics]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: anticoagulant therapy]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge, state of practice: Use of direct oral anticoagulants and warfarin in the context of atrial fibrillation and venous thromboembolism]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Alphanate - von Willebrand disease]
2019     Ontario Health Minimally invasive glaucoma surgery: a budget impact analysis and evaluation of patients’ experiences, preferences, and values
2019     Ontario Health Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2019     Health Quality Ontario (HQO) Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Health Quality Ontario (HQO) Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2018     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of the ultrasonic flowmeter for verification of graft patency during coronary artery bypass grafting]
2018     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of ambulatory electrocardiography technologies for the diagnosis of cardiac arrhythmia]
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for temporomandibular joint disorder: an overview of systematic reviews
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical evaluation of interventions for the management of insomnia: a review of reviews
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for chlamydia trachomatis and neisseria gonorrhoeae during pregnancy: a health technology assessment
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Metastatic melanoma gap analysis
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for the management of rheumatoid arthritis: clinical evaluation
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Composite resin versus amalgam for dental restorations: a health technology assessment
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal strategies for the diagnosis of acute pulmonary embolism: a health technology assessment
2018     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Best practices to reduce medication administration errors (MAEs) in hospital centre (HC) and long term care facilities centre (LTCF)]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of clinical data from electronic medical records for research and continuous quality improvement in front-line care and services]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice in pediatric trauma care: patients admitted to the designated facilities of the trauma care network between 2010 and 2015]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: mild traumatic brain injury, knowledge update in preparation for the revision of the ministerial orientations for mild traumatic brain injury (2005-2010)]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: surgical treatment of the esophagus - quality and accessibility in Quebec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: strategies to optimize the appropriateness of MRI and CT requests - strategies and tools for optimal use]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: a profile of the practices adopted in Quebec to facilitate the transition to adulthood of young people who reside in an alternative living facility]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optimal service trajectory for children, adolescents and young adults with attention deficit disorder with or without hyperactivity (ADHD) or related problems]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: equitable access to the psychotherapy services in Quebec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of the prostate-specific antigen (PSA) test in prostate cancer screening in Québec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the use of EndoPredict and Prosigna for early invasive breast cancer]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: portrait of opioid use in persons covered by Québec’s public prescription drug insurance plan]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: islet transplantation in patients with unstable type I diabetes]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: blepharitis]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: herpes simplex eye disease]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: ministerial standards of access, quality, continuity, efficiency and effectiveness of the service d’intervention de crise dans le milieu 24/7]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: regulation of private congregate living facilities for the elderly]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: living environment quality in long-term care facilities for dependent seniors]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: national and international practices in the organization of rehabilitative care for adults with permanent or temporary motor disabilities]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best practices for runaway prevention and intervention for youths living in rehabilitation centres for young persons with adjustment problems]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, English version updated in June 2020: requirements relating to the institutions responsible for the operation of acute healthcare facilities designated within the Quebec trauma network]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge on organizational models for intensive care units]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: antibiotic prophylaxis during clean orthopedic surgery in children and adults]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Flashglucose monitoring system (Freestyle Libre, Abbott), report updated April 8 2020]
2018     Health Quality Ontario (HQO) Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Bilateral Cochlear Implantation: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Electronic Monitoring Systems to Assess Urinary Incontinence: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Continuous monitoring of glucose for Type 1 diabetes: OHTAC recommendation
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: OHTAC recommendation
2018     Health Quality Ontario (HQO) Continuous monitoring of glucose for Type 1 Diabetes: a health technology assessment
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: a healthtechnology assessment
2017     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Home use of a mechanical cough-assist insufflation-exsufflation device for adults with neuromuscular diseases who do not require ventilatory support]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Dialysis modalities for the treatment of end-stage kidney disease: a health technology assessment
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) New drugs for type 2 diabetes: second-line therapy - science report
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Proton beam therapy for the treatment of cancer in children and adults: a health technology assessment
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Dual antiplatelet therapy following percutaneous coronary intervention: a review of the clinical impact of treatment duration
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for locally advanced oropharyngeal cancer: a systematic review of clinical effectiveness and cost-effectiveness
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for the treatment of obstructive sleep apnea in adults: a health technology assessment
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for hepatitis C virus: a systematic review
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report and optimal usage guide: immunoglobulins in neurology]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report on optimal antipsychotic use and the nonpharmacological management of the behavioural and psychological symptoms of dementia in people with major neurocognitive disorders living in residential and long-term care centers]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Portraits describing pharmacological and non-pharmacological interventions for attention deficit hyperactivity disorder (ADHD) in Quebecers 25 years of age and under]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of introducing a pathogen inactivation process for labile blood products in Quebec]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: organization of the continuum and provision of services to children aged 2 to 9 years with specific language impairment]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: update of proton radiation therapy indications in oncology]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: maintaining a stockpile of influenza antivirals in preparation for a flu pandemic]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal usage guide: cellulitis in adults and children]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: fibrinolysis in ST-segment elevation acute myocardial infarction]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge in support of the decision to integrate new endobronchial ultrasound (EBUS) services in Québec hospitals]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: comparison of cervical cancer screening strategies involving the human papillomavirus screening test (HPV test) or gynecological cytology (Pap test)]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: chemoembolization for unresectable liver metastases according to the primary origin and chemoperfusion for advanced pancreatic cancer]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use, in Québec, of probiotics in the prevention of Clostridium difficile-associated diarrhea in hospitalized patients on antibiotic therapy]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: beta-lactam allergies, assessment of the risk of cross-reactivity with cephalosporins and carbapenems in penicillin-allergic patients]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: statins, lipid-lowering agents and cardiovascular risk reduction]